Genetics Generation Advancement Corp. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 134.31 million compared to TWD 140.86 million a year ago. Net income was TWD 0.863 million compared to TWD 6.32 million a year ago. Basic earnings per share from continuing operations was TWD 0.04 compared to TWD 0.26 a year ago. Diluted earnings per share from continuing operations was TWD 0.04 compared to TWD 0.26 a year ago. Basic earnings per share was TWD 0.04 compared to TWD 0.26 a year ago. Diluted earnings per share was TWD 0.04 compared to TWD 0.26 a year ago.
For the six months, sales was TWD 273.99 million compared to TWD 261.07 million a year ago. Net income was TWD 11.6 million compared to TWD 5.86 million a year ago. Basic earnings per share from continuing operations was TWD 0.48 compared to TWD 0.24 a year ago. Diluted earnings per share from continuing operations was TWD 0.48 compared to TWD 0.24 a year ago. Basic earnings per share was TWD 0.48 compared to TWD 0.24 a year ago. Diluted earnings per share was TWD 0.48 compared to TWD 0.24 a year ago.